Recent clinical data, obtained with either chimeric TNF-α antibodies or soluble TNF-α receptor in the treatment of rheumatoid arthritis and Crohn’s disease, have confirmed the key role of TNF-α in these inflammatory disorders [5,6,7,8,9]. Here, TNF is linked to Crohn disease.